Deglazer

Principle Routes of Exposure

Eye, Skin, Ingestion and Inhalation Target Organs: Eyes, skin, respiratory system, central nervous system, liver, blood, reproductive system, kidneys and heart. Eye Contact: May cause moderate irritation. Liquid or vapor may cause burning sensation, pain, watering, change of vision, eye injury and severe eye damage. Skin Contact: May cause mild irritation. Prolonged and repeated contact with skin can cause defatting and drying of the skin which may result in skin irritation and dermatitis. Prolonged and repeated exposure may cause cracking inflammation, Contact may cause sensitization. Skin Absorption: May be harmful if absorbed through skin. Ingestion: Nausea, vomiting, diarrhea, drowsiness, cramps, in coordination, loss of consciousness, difficulty with speech, central nervous system depression, headache, dizziness, drowsiness, mental sluggishness and death in significant exposures. May cause damage to the liver and kidneys. May cause effects similar to inhalation. Inhalation: May irritate nose, throat, respiratory tract. May cause nasal discomfort and discharge, hoarseness, coughing, chest pain, difficulty breathing, nausea, headache, dizziness, drowsiness, loss of appetite, vomiting and diarrhea. High vapor concentration may cause central nervous system depression, vertigo, emotional labiality, accelerated pulse, face redness, kidney and liver damage, unconsciousness, occasional urinary and fecal incontinence.

Medical Conditions Generally Aggravated by Exposure

to Product Eye disorders, skin disorders, respiratory system disorders, central nervous system disorders, liver disorders and impaired respiratory function. Other: Chronic exposure may produce anemia, bronchitis, leucocitosis, edema, blurry cornea, liver, kidney and heart damages, blood alterations and greasy degeneration of the viscera.

Cancer information

This product does not contain 0.1% or more of the known or potential carcinogens listed in NTP, IARC or OSHA. The International Agency for Research on Cancer (IARC) has determined that consumption of alcoholic beverages is causally related to the occurrence of malignant tumors of the oral cavity, pharynx, larynx, esophagus and liver in humans. The carcinogenic response attributed to drinking alcoholic beverages has not been verified in studies with laboratory animals. Established use of denatured ethanol and non- beverage uses of pure ethanol are not considered to pose any significant cancer hazard. The American Conference of Governmental Industrial Hygienists (ACGIH) lists Ethanol as an A4 – Not Classified as a Human Carcinogen.

Environmental effects

See Section 12